TERIAK

AEROFOR

AEROFOR

DCI : FORMOTEROL

Indications

1 / Continuous symptomatic treatment of asthma and other reversible obstructive pulmonary disease; - for patients requiring daily intakes of short-acting and short-acting beta2 agonists, - and / or in the event of nocturnal symptoms, in combination with continuous anti-inflammatory treatment such as inhaled corticosteroids.

2 / Preventive treatment of exercise-induced asthma. N.B .: formoterol is not a treatment for an asthma attack. In the event of an asthma attack, use a short-acting beta 2 mimetic of short duration by inhalation or depending on the severity by injection. This specialty is particularly suitable for subjects in whom poor hand / lung synchronization has been demonstrated necessary for the correct use of conventional metered dose aerosols without an inhalation chamber.